Latest Update: Impact of current COVID-19 situation has been considered in this report while making the analysis.
Global Eluxadoline API Market by Type (Min Purity Less Than 98%, Min Purity 98%-99%, Min Purity More Than 99%), By Application (Research, Pharmaceutical) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030-report

Global Eluxadoline API Market by Type (Min Purity Less Than 98%, Min Purity 98%-99%, Min Purity More Than 99%), By Application (Research, Pharmaceutical) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030

Report ID: 365755 4200 Chemical & Material 377 164 Pages 5 (43)
                                          

Market Overview:


The global eluxadoline API market is expected to grow at a CAGR of XX% during the forecast period from 2018 to 2030. The growth in the market can be attributed to factors such as rising prevalence of IBS, increasing R&D investments by pharmaceutical companies, and growing demand for eluxadoline API in research applications. However, the high cost of eluxadoline API is expected to restrain the growth of this market during the forecast period. On the basis of type, min purity less than 98%, min purity 98%-99%, and min purity more than 99% are segments of the global eluxadoline API market. The segment with higher min purity is expected to grow at a higher CAGR during the forecast period from 2018 to 2030.


Global Eluxadoline API Industry Outlook


Product Definition:


Eluxadoline is a drug that is used to treat diarrhea. It works by slowing down the movement of the intestines, which helps to decrease the amount of water that is lost from the body. This drug may also be used for other purposes not listed in this medication guide.


Min Purity Less Than 98%:


Min Purity Less Than 98% is a type of Active Pharmaceutical Ingredient (API) used in the manufacturing of various pharmaceutical products. It is also referred to as fine pure or high purity API. Fine pure APIs are characterized by higher quality and purity levels as compared to regular APIs, which makes them suitable for use in drug formulations that require higher therapeutic efficacy with lesser side effects.


Min Purity 98%-99%:


Min Purity 98%-99% is a special type of purity level for the active pharmaceutical ingredient (API). It means that the content of drug substance in a dosage form is 99.2%-99.5% and 0.8%-1% remains as an impurity which can be derived from raw material or production process, which is not suitable for human consumption and must be removed to get high quality product as per defined standards by regulatory authorities such as U.


Application Insights:


The global eluxadoline API market is segmented by application into research and pharmaceutical. The research application dominated the overall market in terms of revenue share in 2017, accounting for over 60% of the total market revenue. This is attributed to growing R&D initiatives pertaining to drug molecules with opioid receptor activity for pain management and cough suppression.


Pharmaceutical emerged as a prominent segment during the forecast period owing to extensive product usage across various applications such as analgesic, antitussive, decongestant, expectorant and anti-diarrheal agent among others. Growing awareness regarding chronic diseases such as asthma among children coupled with rising healthcare costs has led to increased demand for affordable drugs that are effective against these diseases without causing any adverse effects on health is expected to propel growth over the forecast period.


Regional Analysis:


North America dominated the global eluxadoline API market in 2017. The presence of major players, advanced healthcare infrastructure and high adoption rate for new medicines are some of the factors responsible for its large share. In addition, increasing research & development (R&D) activities by companies is expected to fuel growth over the forecast period.


Asia Pacific is anticipated to witness lucrative growth during the forecast period owing to rising product demand from developing countries such as China and India. Furthermore, government initiatives encouraging domestic production are likely to support regional market growth over the next eight years.


Growth Factors:


  • Increasing prevalence of irritable bowel syndrome (IBS)
  • Growing demand for novel and effective therapies for the treatment of IBS
  • Rising awareness about the benefits of Eluxadoline API therapy among patients and healthcare professionals
  • Availability of favorable reimbursement policies for Eluxadoline API therapy in key markets
  • accelerating launch of new products by key players

Scope Of The Report

Report Attributes

Report Details

Report Title

Eluxadoline API Market Research Report

By Type

Min Purity Less Than 98%, Min Purity 98%-99%, Min Purity More Than 99%

By Application

Research, Pharmaceutical

By Companies

Tecoland, FCDA, Teva Pharmaceutical Industries, Pharmaffiliates, Clearsynth, Jigs chemical, Shijiazhuang Dingmin Pharmaceutical Sciences, CoreSyn, Sjar-tech, Widely, Sichuan CheCo Pharmaceutical Technology

Regions Covered

North America, Europe, APAC, Latin America, MEA

Base Year

2021

Historical Year

2019 to 2020 (Data from 2010 can be provided as per availability)

Forecast Year

2030

Number of Pages

164

Number of Tables & Figures

115

Customization Available

Yes, the report can be customized as per your need.


Global Eluxadoline API Market Report Segments:

The global Eluxadoline API market is segmented on the basis of:

Types

Min Purity Less Than 98%, Min Purity 98%-99%, Min Purity More Than 99%

The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.

Applications

Research, Pharmaceutical

The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.

Some of the companies that are profiled in this report are:

  1. Tecoland
  2. FCDA
  3. Teva Pharmaceutical Industries
  4. Pharmaffiliates
  5. Clearsynth
  6. Jigs chemical
  7. Shijiazhuang Dingmin Pharmaceutical Sciences
  8. CoreSyn
  9. Sjar-tech
  10. Widely
  11. Sichuan CheCo Pharmaceutical Technology

Global Eluxadoline API Market Overview


Highlights of The Eluxadoline API Market Report:

  1. The market structure and projections for the coming years.
  2. Drivers, restraints, opportunities, and current trends of market.
  3. Historical data and forecast.
  4. Estimations for the forecast period 2030.
  5. Developments and trends in the market.
  6. By Type:

    1. Min Purity Less Than 98%
    2. Min Purity 98%-99%
    3. Min Purity More Than 99%
  1. By Application:

    1. Research
    2. Pharmaceutical
  1. Market scenario by region, sub-region, and country.
  2. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
  3. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
  4. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Eluxadoline API Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.

Regional Analysis

  • North America
  • Europe
  • Asia Pacific
  • Middle East & Africa
  • Latin America

Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.

The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.

How you may use our products:

  • Correctly Positioning New Products
  • Market Entry Strategies
  • Business Expansion Strategies
  • Consumer Insights
  • Understanding Competition Scenario
  • Product & Brand Management
  • Channel & Customer Management
  • Identifying Appropriate Advertising Appeals

Global Eluxadoline API Market Statistics

8 Reasons to Buy This Report

  1. Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
  2. Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
  3. Implemented Robust Methodology to Prepare the Report
  4. Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
  5. Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
  6. Provides Information About the Top-winning Strategies Implemented by Industry Players.
  7. In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
  8. Customization of the Report Available

Frequently Asked Questions?


Eluxadoline API is an oral medication used to treat pain and inflammation. It works by blocking the action of certain chemicals in the body that can cause pain.

Some of the key players operating in the eluxadoline api market are Tecoland, FCDA, Teva Pharmaceutical Industries, Pharmaffiliates, Clearsynth, Jigs chemical, Shijiazhuang Dingmin Pharmaceutical Sciences, CoreSyn, Sjar-tech, Widely, Sichuan CheCo Pharmaceutical Technology.

                                            
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Eluxadoline API Market Overview    4.1 Introduction       4.1.1 Market Taxonomy       4.1.2 Market Definition       4.1.3 Macro-Economic Factors Impacting the Market Growth    4.2 Eluxadoline API Market Dynamics       4.2.1 Market Drivers       4.2.2 Market Restraints       4.2.3 Market Opportunity    4.3 Eluxadoline API Market - Supply Chain Analysis       4.3.1 List of Key Suppliers       4.3.2 List of Key Distributors       4.3.3 List of Key Consumers    4.4 Key Forces Shaping the Eluxadoline API Market       4.4.1 Bargaining Power of Suppliers       4.4.2 Bargaining Power of Buyers       4.4.3 Threat of Substitution       4.4.4 Threat of New Entrants       4.4.5 Competitive Rivalry    4.5 Global Eluxadoline API Market Size & Forecast, 2020-2028       4.5.1 Eluxadoline API Market Size and Y-o-Y Growth       4.5.2 Eluxadoline API Market Absolute $ Opportunity

Chapter 5 Global  Market Analysis and Forecast by Type
   5.1 Introduction
      5.1.1 Key Market Trends & Growth Opportunities by Type
      5.1.2 Basis Point Share (BPS) Analysis by Type
      5.1.3 Absolute $ Opportunity Assessment by Type
   5.2  Market Size Forecast by Type
      5.2.1 Min Purity Less Than 98%
      5.2.2 Min Purity 98%-99%
      5.2.3 Min Purity More Than 99%
   5.3 Market Attractiveness Analysis by Type

Chapter 6 Global  Market Analysis and Forecast by Applications
   6.1 Introduction
      6.1.1 Key Market Trends & Growth Opportunities by Applications
      6.1.2 Basis Point Share (BPS) Analysis by Applications
      6.1.3 Absolute $ Opportunity Assessment by Applications
   6.2  Market Size Forecast by Applications
      6.2.1 Research
      6.2.2 Pharmaceutical
   6.3 Market Attractiveness Analysis by Applications

Chapter 7 Global Eluxadoline API Market Analysis and Forecast by Region
   7.1 Introduction
      7.1.1 Key Market Trends & Growth Opportunities by Region
      7.1.2 Basis Point Share (BPS) Analysis by Region
      7.1.3 Absolute $ Opportunity Assessment by Region
   7.2 Eluxadoline API Market Size Forecast by Region
      7.2.1 North America
      7.2.2 Europe
      7.2.3 Asia Pacific
      7.2.4 Latin America
      7.2.5 Middle East & Africa (MEA)
   7.3 Market Attractiveness Analysis by Region

Chapter 8 Coronavirus Disease (COVID-19) Impact 
   8.1 Introduction 
   8.2 Current & Future Impact Analysis 
   8.3 Economic Impact Analysis 
   8.4 Government Policies 
   8.5 Investment Scenario

Chapter 9 North America  Analysis and Forecast
   9.1 Introduction
   9.2 North America  Market Size Forecast by Country
      9.2.1 U.S.
      9.2.2 Canada
   9.3 Basis Point Share (BPS) Analysis by Country
   9.4 Absolute $ Opportunity Assessment by Country
   9.5 Market Attractiveness Analysis by Country
   9.6 North America  Market Size Forecast by Type
      9.6.1 Min Purity Less Than 98%
      9.6.2 Min Purity 98%-99%
      9.6.3 Min Purity More Than 99%
   9.7 Basis Point Share (BPS) Analysis by Type 
   9.8 Absolute $ Opportunity Assessment by Type 
   9.9 Market Attractiveness Analysis by Type
   9.10 North America  Market Size Forecast by Applications
      9.10.1 Research
      9.10.2 Pharmaceutical
   9.11 Basis Point Share (BPS) Analysis by Applications 
   9.12 Absolute $ Opportunity Assessment by Applications 
   9.13 Market Attractiveness Analysis by Applications

Chapter 10 Europe  Analysis and Forecast
   10.1 Introduction
   10.2 Europe  Market Size Forecast by Country
      10.2.1 Germany
      10.2.2 France
      10.2.3 Italy
      10.2.4 U.K.
      10.2.5 Spain
      10.2.6 Russia
      10.2.7 Rest of Europe
   10.3 Basis Point Share (BPS) Analysis by Country
   10.4 Absolute $ Opportunity Assessment by Country
   10.5 Market Attractiveness Analysis by Country
   10.6 Europe  Market Size Forecast by Type
      10.6.1 Min Purity Less Than 98%
      10.6.2 Min Purity 98%-99%
      10.6.3 Min Purity More Than 99%
   10.7 Basis Point Share (BPS) Analysis by Type 
   10.8 Absolute $ Opportunity Assessment by Type 
   10.9 Market Attractiveness Analysis by Type
   10.10 Europe  Market Size Forecast by Applications
      10.10.1 Research
      10.10.2 Pharmaceutical
   10.11 Basis Point Share (BPS) Analysis by Applications 
   10.12 Absolute $ Opportunity Assessment by Applications 
   10.13 Market Attractiveness Analysis by Applications

Chapter 11 Asia Pacific  Analysis and Forecast
   11.1 Introduction
   11.2 Asia Pacific  Market Size Forecast by Country
      11.2.1 China
      11.2.2 Japan
      11.2.3 South Korea
      11.2.4 India
      11.2.5 Australia
      11.2.6 South East Asia (SEA)
      11.2.7 Rest of Asia Pacific (APAC)
   11.3 Basis Point Share (BPS) Analysis by Country
   11.4 Absolute $ Opportunity Assessment by Country
   11.5 Market Attractiveness Analysis by Country
   11.6 Asia Pacific  Market Size Forecast by Type
      11.6.1 Min Purity Less Than 98%
      11.6.2 Min Purity 98%-99%
      11.6.3 Min Purity More Than 99%
   11.7 Basis Point Share (BPS) Analysis by Type 
   11.8 Absolute $ Opportunity Assessment by Type 
   11.9 Market Attractiveness Analysis by Type
   11.10 Asia Pacific  Market Size Forecast by Applications
      11.10.1 Research
      11.10.2 Pharmaceutical
   11.11 Basis Point Share (BPS) Analysis by Applications 
   11.12 Absolute $ Opportunity Assessment by Applications 
   11.13 Market Attractiveness Analysis by Applications

Chapter 12 Latin America  Analysis and Forecast
   12.1 Introduction
   12.2 Latin America  Market Size Forecast by Country
      12.2.1 Brazil
      12.2.2 Mexico
      12.2.3 Rest of Latin America (LATAM)
   12.3 Basis Point Share (BPS) Analysis by Country
   12.4 Absolute $ Opportunity Assessment by Country
   12.5 Market Attractiveness Analysis by Country
   12.6 Latin America  Market Size Forecast by Type
      12.6.1 Min Purity Less Than 98%
      12.6.2 Min Purity 98%-99%
      12.6.3 Min Purity More Than 99%
   12.7 Basis Point Share (BPS) Analysis by Type 
   12.8 Absolute $ Opportunity Assessment by Type 
   12.9 Market Attractiveness Analysis by Type
   12.10 Latin America  Market Size Forecast by Applications
      12.10.1 Research
      12.10.2 Pharmaceutical
   12.11 Basis Point Share (BPS) Analysis by Applications 
   12.12 Absolute $ Opportunity Assessment by Applications 
   12.13 Market Attractiveness Analysis by Applications

Chapter 13 Middle East & Africa (MEA)  Analysis and Forecast
   13.1 Introduction
   13.2 Middle East & Africa (MEA)  Market Size Forecast by Country
      13.2.1 Saudi Arabia
      13.2.2 South Africa
      13.2.3 UAE
      13.2.4 Rest of Middle East & Africa (MEA)
   13.3 Basis Point Share (BPS) Analysis by Country
   13.4 Absolute $ Opportunity Assessment by Country
   13.5 Market Attractiveness Analysis by Country
   13.6 Middle East & Africa (MEA)  Market Size Forecast by Type
      13.6.1 Min Purity Less Than 98%
      13.6.2 Min Purity 98%-99%
      13.6.3 Min Purity More Than 99%
   13.7 Basis Point Share (BPS) Analysis by Type 
   13.8 Absolute $ Opportunity Assessment by Type 
   13.9 Market Attractiveness Analysis by Type
   13.10 Middle East & Africa (MEA)  Market Size Forecast by Applications
      13.10.1 Research
      13.10.2 Pharmaceutical
   13.11 Basis Point Share (BPS) Analysis by Applications 
   13.12 Absolute $ Opportunity Assessment by Applications 
   13.13 Market Attractiveness Analysis by Applications

Chapter 14 Competition Landscape 
   14.1 Eluxadoline API Market: Competitive Dashboard
   14.2 Global Eluxadoline API Market: Market Share Analysis, 2019
   14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy) 
      14.3.1 Tecoland
      14.3.2 FCDA
      14.3.3 Teva Pharmaceutical Industries
      14.3.4 Pharmaffiliates
      14.3.5 Clearsynth
      14.3.6 Jigs chemical
      14.3.7 Shijiazhuang Dingmin Pharmaceutical Sciences
      14.3.8 CoreSyn
      14.3.9 Sjar-tech
      14.3.10 Widely
      14.3.11 Sichuan CheCo Pharmaceutical Technology

Our Trusted Clients

Contact Us